Enroll in Research > Research Search & Enroll Tool > Men at High Genetic Risk for Prostate Cancer
Men at High Genetic Risk for Prostate Cancer

Men at High Genetic Risk for Prostate Cancer

Clinicaltrials.gov identifier:


Study Contact Information:

Anna Couvillon, Nurse Practitioner
By phone: (240) 858-3148
or by email 

Men at High Genetic Risk for Prostate Cancer

About the Study

The National Cancer Institute opened a clinical trial for prostate cancer screening in men who are at high risk for prostate cancer due to an inherited mutation. 

View the study on ClinicalTrials.gov or contact Anna Couvillon, NP at: (240) 858-3148 or by email. 

What the Study Entails

  • Screening MRI of the prostate every 2 years
  • Annual PSA blood test
  • Biopsy of the prostate if any MRIs are abnormal
  • No cost for study-related tests or procedures
  • No cost for travel
  • Clinical information will be shared with you and your doctor, if you choose
  • Genetic testing is not offered as part of the study

Study Lead Investigator

William L Dahut, MD, National Cancer Institute (NCI)

Study Site

The National Institutes of Health (NIH), Clinical Center
Bethesda, MD in the Washington, DC metro area
NIH can cover the cost of travel for participants


This Study is Open To:
  • Men, 30 to 75 years old without prostate cancer, who have tested positive for BRCA1, BRCA2, HOXB13, NBN, TP53, Lynch syndrome (MLH1, MSH2, MSH6, PMS2, EPCAM), CHEK2, PALB2, RAD51C, RAD51D, BRIP1, FANCA or ATM mutation.
  • Genetic testing is not offered.
This Study is Not Open To:
  • Men who have already been diagnosed with prostate cancer